Profile for ChemoCentryx Inc. (CCXI)

$ 43.24   0.64 (+1.50%) Volume: 623.66k 4:00 PM EDT 8-Apr-2020
After Hours:  $ 43.24 0.00 (0.00%) Volume: 8.02k 4:41 PM EDT 8-Apr-2020
Business Description:
ChemoCentryx Inc is a biopharmaceutical company. It is engaged in discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.
Address: 850 Maude Avenue, Mountain View, CA, USA, 94043
Telephone: +1 650 210-2900 Website:
Facsimile: +1 650 210-2910 Email: [email protected]
CEO: Thomas J. Schall
Employees: 82 Market Cap: 2.67b
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1340652
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC: Pharmaceutical Preparations (2834)